Health Care/Hospital

New Regulatory Team at Quintiles Helps Bring Biotechnology Products to Market

Former FDA, Industry Experts Have More Than 115 Years of Experience RESEARCH TRIANGLE PARK, N.C., May 8 /Xinhua-PRNewswire/ -- Quintiles Transnational Corp. today announced the formation of a global biologics regulatory team to advise customers about development plans and optimal strategy f...

2007-05-09 09:02 792

Singapore Attracts Four Major Biologics Manufacturing Investments Totaling Close to US$1 Billion in Less Than Two Years

BOSTON, May 8 /Xinhua-PRNewswire/ -- Having established a reputation as the most competitive and trusted site for pharmaceutical bulk activities and secondary manufacturing, Singapore is now aggressively pursuing investments in biologics (Note 1), an area that will drive growth in the drug indus...

2007-05-09 03:30 690

China Biopharmaceuticals Names New Officer and Directors

Ms. Zhang Jian named Chairwoman of the Board Mr. Shi Mingsheng appointed Chief Operating Officer Mr. Ding Weihua appointed to the Board of Directors BEIJING, May 7 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading pharmaceutic...

2007-05-08 10:21 593

3SBio Inc. to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference and the Merrill Lynch Pan Asia Rising Stars Conference

SHENYANG, China, May 7 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, will present at the UBS Global Generic and Specialty Pharmaceuticals Conferen...

2007-05-08 09:59 816

World's Leading Pharmaceutical Companies Make Significant Expansions to Their Corporate Research Laboratories in Singapore

Continued Growth is a Strong Endorsement of Singapore as a Location for Drug Discovery & Development BOSTON, May 7 /Xinhua-PRNewswire/ -- Singapore's position as a location for cutting-edge research and development (R&D) was further validated when leading drug makers Lilly, GlaxoSmithKline ...

2007-05-07 21:00 635

Protelos(R): First Osteoporosis Treatment to Show Long-Term, Sustained Efficacy and Quality of Life Improvement

-- New Data Show Clear Benefit of Protelos(R) in Wide Range of Osteoporosis Patients Irrespective of Disease Severity COPENHAGEN, Denmark, May 7 /Xinhua-PRNewswire/ -- New, long term data presented at the 34th European Symposium on Calcified Tissues (ECTS) this week underscore the unma...

2007-05-07 16:17 830

3SBio Inc. Announces First Quarter 2007 Results

- Q1 2007 net revenues grew 26.0%, as compared to Q1 2006, to US$4.6 million - Q1 2007 operating income up 26.9% over Q1 2006, to US $1.5 million - Q1 2007 net income grew 116.3%, as compared to Q1 2006, to US$2.1 million SHENYANG, China, May 2 /Xinhua-PRNews...

2007-05-02 10:48 768

Simcere Pharmaceutical Group to Announce 2007 First Quarter Earnings on Tuesday, May 15, 2007

NANJING, China, April 30 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals in the rapidly growing Chinese marketplace, announced today that it intends to release its 2007 first quarter earnings on Tuesday, ...

2007-04-30 22:00 643

Sinovac to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals Conference

BEIJING, April 30 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, announced today that it has scheduled to present at the 2007 UBS Global Generic and Specialty Pharmaceuticals Conference on Tuesday, May 8, 2007. Weidong Yin, ...

2007-04-30 20:00 753

Corning Announces $300 Million Research and Development Facility Investment

Multi-year Facility Plan Supports Strategy to Double Rate of Innovation CORNING, N.Y., April 29 /Xinhua-PRNewswire/ -- Corning Incorporated (NYSE: GLW) announced April 26 that its Board of Directors has approved a $300 million facility improvement plan for the company's Sullivan Park Resear...

2007-04-29 14:08 778

Corning Announces First-Quarter Results

-- EPS exceeds guidance -- LCD market estimates increased CORNING, N.Y., April 27 /Xinhua-PRNewswire/ -- Corning Incorporated (NYSE: GLW) on April 25th 2007 announced first-quarter sales of $1.31 billion and net income of $327 million, or $0.20 per share. (Logo: http://www...

2007-04-27 16:02 874

3SBio Inc. Schedules 2007 First Quarter Earnings Release on Tuesday, May 1, 2007

Earnings Conference Call to be held on May 2, 2007 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) SHENYANG, China, April 27 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China based biotechnology company focused on researching, developing, manufacturing...

2007-04-27 04:05 778

China Sky One Medical Receives Research & Development Grant From

HARBIN, China, April 26 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), one of the leading producers and distributors for external-Chinese medicine in China, has received a grant from the Heilongjiang government (USD $500,000) to perform monoclonal anti...

2007-04-26 20:00 925

Tarceva(R) Extends Life of Patients with Pancreatic Cancer

Newly published results show significant improvement in survival when innovative, oral cancer drug Tarceva is added to chemotherapy BASEL, Switzerland, April 26 /Xinhua-PRNewswire/ -- New results published by the Journal of Clinical Oncology show that adding Tarceva (erlotinib) to gemcitab...

2007-04-26 17:44 804

Genesis Bioventures, Inc. Announced Today that the Company is Participating in the 2007 International Capital and China Industrial Development Forum in Beijing, China

LOS ANGELES, April 26 /Xinhua-PRNewswire/ -- Mr. Douglas C. Lane, CEO, stated today that Genesis Bioventures, Inc. were invited to participate in the 2007 International Capital and China Industrial Development Forum in Beijing. The Company's agent for the Mad Cow testing in the Pacific Rim, Mr...

2007-04-26 15:51 733

Synamatix Announces Release of Bioinformatics Solutions for Second Generation Sequencers

KUALA LUMPUR, Malaysia, April 24 /Xinhua-PRNewswire/ -- Synamatix announced today the release of two new software applications designed to process and analyse data from large-scale re-sequencing projects conducted with second generation DNA sequencing platforms. Robert Hercus, Synamati...

2007-04-24 08:00 638

BioLife Remedies Announces: Official Release of DI-AGRA

VANCOUVER, BC and GUANGZHOU, April 24 /Xinhua-PRNewswire/ -- BioLife Remedies Inc. (PINKSHEETS: BLRS) is pleased to announce that DI-AGRA(TM) will be available for sale in May 2007. DI-AGRA(TM) is a herbal product developed by the Company for men with Erectile Dysfunction from Diabetes. ...

2007-04-24 12:57 828

Mindray to Report First Quarter 2007 Financial Results on May 14, 2007

SHENZHEN, China, April 23 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China, today announced that it will report its financial results for the first quarter 2007 after the U.S. market cl...

2007-04-23 20:00 709

Zhongpin Implements New Supply Chain Management and Logistics Systems

CHANGGE CITY, China, April 23 /Xinhua-PRNewswire-FirstCall/ -- Zhongpin Inc. (OTC Bulletin Board: ZHNP), a leading meat and food processing company in the People's Republic of China ("PRC"), announced today that it has implemented the first phase of a new advanced planning and scheduling ("APS...

2007-04-23 20:30 849

Varian Medical Systems to Exhibit New Clinac CX Medical Linear Accelerator and Other Cancer Treatment Technologies at ChinaMed Exhibition in Beijing

Varian to showcase full spectrum of hardware and software products, including turnkey packages for launching radiotherapy treatment programs BEIJING, April 20 /Xinhua-PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading manufacturer of medical devices and software ...

2007-04-20 09:00 1140
1 ... 524525526527528529530 ... 535